FB2026_02 , released June 18, 2026
Human Disease Model Report: Van Maldergem syndrome 2
Open Close
General Information
Name
Van Maldergem syndrome 2
FlyBase ID
FBhh0001081
Disease Ontology Term
Parent Disease
Overview

This report describes Van Maldergem syndrome 2, which shows autosomal recessive inheritance. The human gene implicated in this disease, FAT4, is also implicated in a similar neurodevelopmental disorder, Hennekam lymphangiectasia-lymphedema syndrome 2 (FBhh0001082, MIM:616006, DOID:0060366). See the report for 'neurodevelopmental disorders, FAT4-related' (FBhh0001080) for information on experimental results using Drosophila models of this and related diseases.

[updated July 2019 by FlyBase; FBrf0222196]

Disease Summary Information
Disease Summary: Van Maldergem syndrome 2
OMIM report

[VAN MALDERGEM SYNDROME 2; VMLDS2](https://omim.org/entry/615546)

Human gene(s) implicated

[FAT ATYPICAL CADHERIN 4; FAT4](https://omim.org/entry/612411)

Symptoms and phenotype

VMS is characterized by intellectual disability, periventricular heterotopia, an unusual face, camptodactyly and syndactyly, small kidneys, osteoporosis and tracheal anomalies sometimes necessitating tracheostomy. (Alders et al. 2014, pubmed:24913602.)

Van Maldergem syndrome is an autosomal recessive disorder characterized by intellectual disability, typical craniofacial features, auditory malformations resulting in hearing loss, and skeletal and limb malformations. Some patients have renal hypoplasia. Brain MRI typically shows periventricular nodular heterotopia (summary by Cappello et al. 2013, pubmed:24056717).

[from MIM:615546, 2019.7.17]

Genetics

In 5 patients from 4 unrelated families with Van Maldergem syndrome-2, Cappello et al. 2013 (pubmed:24056717) identified biallelic mutations in the FAT4 gene. [from MIM:615546, 2019.7.17]

Cellular phenotype and pathology
Molecular information

VMS-1 is caused by recessive mutations in the DCHS1 gene (dachsous cadherin-related 1 [Homo sapiens]) on chromosome 11p15.4, while VMS-2 is caused by recessive mutations in the FAT4 gene (Fat tumor suppressor, Drosophila of 4), on chromosome 4q28.1. DCHS1 protein is the ligand for the FAT4 receptor. Dchs1-Fat4 influence planar cell polarity (PCP), the polarization of cell structures and behaviors (direction of movement) within the plane of a tissue. PCP is essential for the generation of tissue architecture during embryogenesis and for postnatal growth and tissue repair. (Sotos et al. 2017, pubmed:29046692.)

The FAT4 gene encodes a protein that is a member of a large family of protocadherins. DCHS1 (MIM:603057) is another protocadherin that is the ligand for FAT4; FAT4 and DCHS1 form an apically located adhesive complex in the developing brain (summary by Cappello et al. 2013, pubmed:24056717). [from MIM:612411, 2019.7.16]

External links
Disease synonyms
VMLDS2
VMS
Ortholog Information
Human gene(s) in FlyBase
    Other mammalian ortholog(s) used
      D. melanogaster Gene Information (0)
      Other Genes Used: Viral, Bacterial, Synthetic (0)
        Summary of Physical Interactions (0 groups)
        Alleles Reported to Model Human Disease (Disease Ontology) (0 alleles)
        Alleles Representing Disease-Implicated Variants
        Genetic Tools, Stocks and Reagents
        Sources of Stocks
        Contact lab of origin for a reagent not available from a public stock center.
        Bloomington Stock Center Disease Page
        Related mammalian, viral, bacterial, or synthetic transgenes
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila transgenes
        Allele
        Transgene
        Publicly Available Stocks
        RNAi constructs available
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila classical alleles
        Allele
        Allele class
        Mutagen
        Publicly Available Stocks
        References (2)